High risk of intraocular pressure rise with difluprednate post collagen cross-linking for keratoconus

High risk of intraocular pressure rise with difluprednate post collagen cross-linking for keratoconus

Purpose: To report intraocular pressure (IOP) after use of difluprednate ophthalmic solution 0.05% (Durezol®; Novartis AG, Basilea, Switzerland) post corneal cross-linking (CXL) versus prednisolone (Pred-Forte®; Allergan Inc., Irvine, CA, USA). Methods: A retrospective single-center case series eval...

Full description

Bibliographic Details
Main Authors: Sofia Ramos Bartolomei, Lilia Rivera Román
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:The Pan-American Journal of Ophthalmology
Subjects:
corneal cross-linking
intraocular pressure
keratoconus
Online Access:http://www.thepajo.org/article.asp?issn=2666-4909;year=2021;volume=3;issue=1;spage=14;epage=14;aulast=Bartolomei

Internet

http://www.thepajo.org/article.asp?issn=2666-4909;year=2021;volume=3;issue=1;spage=14;epage=14;aulast=Bartolomei

Similar Items